文献速递乳腺外科围术期管理与 ERAS

整合种族差异的乳腺癌相关淋巴水肿预测模型的可行性与临床实用性

Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence.
PubMed 文献 · JAMA Surg · 2023-01-01

本研究基于1999至2020年两家中心1882例接受腋窝淋巴结手术的乳腺癌女性,构建并验证了术前和术后淋巴水肿预测模型。黑人女性淋巴水肿发生率显著更高(22.1% vs 其他种族,P<.001)。两个模型均纳入种族因素,术前模型外部验证AUC为0.75(95%CI 0.74-0.76),术后模型内部验证AUC为0.82(95%CI 0.79-0.85),准确性较高。

要点

  • 黑人女性乳腺癌相关淋巴水肿发生率显著高于其他种族(22.1% vs 10.1%-14.8%,P<.001)。
  • 术前模型纳入年龄、体重、身高、种族、腋窝手术方式、放疗和化疗,外部验证AUC为0.75。
  • 术后模型纳入年龄、体重、种族、腋窝手术方式、化疗和患者报告手臂肿胀,内部验证AUC为0.82。

核心结论

  • 术前和术后淋巴水肿预测模型准确性高且临床实用,输入变量易获取,并强调种族差异对风险的影响。
  • 术前模型可识别需密切监测或预防措施的高危患者,术后模型可用于筛查高危患者以减少频繁门诊和手臂体积测量。

研究设计与样本

  • 预后研究,纳入1999至2020年在Memorial Sloan Kettering Cancer Center和Mayo Clinic接受腋窝淋巴结清扫或前哨淋巴结活检的乳腺癌女性1882例。

主要发现

  • 1882例患者均为女性,平均(SD)年龄55.6(12.2)岁;黑人女性淋巴水肿发生率22.1%(42/190),显著高于其他种族(P<.001)。
  • 模型1在 cutoff 0.18 时准确性73.0%,敏感性76.6%,特异性72.5%,AUC 0.78(95%CI 0.75-0.81);外部验证AUC 0.75(95%CI 0.74-0.76)。
  • 模型2在 cutoff 0.10 时准确性81.1%,敏感性78.0%,特异性81.5%,AUC 0.86(95%CI 0.83-0.88);内部验证AUC 0.82(95%CI 0.79-0.85)。

关键数值与推荐

  • 模型1纳入年龄、体重、身高、种族、ALND/SLNB状态、任何放疗和任何化疗。
  • 模型2纳入年龄、体重、种族、ALND/SLNB状态、任何化疗和患者报告的手臂肿胀。

临床怎么用

  • 术前模型可用于识别高危患者,指导密切监测或预防措施。
  • 术后模型可用于筛查高危患者,减少频繁门诊和手臂体积测量的需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Breast cancer-related lymphedema (BCRL) is a common complication of axillary lymph node dissection (ALND) but can also develop after sentinel lymph node biopsy (SLNB). Several models have been developed to predict the risk of disease development before and after surgery; however, these models have shortcomings that include the omission of race, inclusion of variables that are not readily available to patients, low sensitivity or specificity, and lack of risk assessment for patients treated with SLNB. OBJECTIVE: To create simple and accurate prediction models for BCRL that can be used to estimate preoperative or postoperative risk. DESIGN, SETTING, AND PARTICIPANTS: In this prognostic study, women with breast cancer who underwent ALND or SLNB from 1999 to 2020 at Memorial Sloan Kettering Cancer Center and the Mayo Clinic were included. Data were analyzed from September to December 2022. MAIN OUTCOMES AND MEASURES: Diagnosis of lymphedema based on measurements. Two predictive models were formulated via logistic regression: a preoperative model (model 1) and a postoperative model (model 2). Model 1 was externally validated using a cohort of 34 438 patients with an International Classification of Diseases diagnosis of breast cancer. RESULTS: Of 1882 included patients, all were female, and the mean (SD) age was 55.6 (12.2) years; 80 patients (4.3%) were Asian, 190 (10.1%) were Black, 1558 (82.8%) were White, and 54 (2.9%) were another race (including American Indian and Alaska Native, other race, patient refused to disclose, or unknown). A total of 218 patients (11.6%) were diagnosed with BCRL at a mean (SD) follow-up of 3.9 (1.8) years. The BCRL rate was significantly higher among Black women (42 of 190 [22.1%]) compared with all other races (Asian, 10 of 80 [12.5%]; White, 158 of 1558 [10.1%]; other race, 8 of 54 [14.8%]; P < .001). Model 1 included age, weight, height, race, ALND/SLNB status, any radiation therapy, and any chemotherapy. Model 2 included age, weight, race, ALND/SLNB status, any chemotherapy, and patient-reported arm swelling. Accuracy was 73.0% for model 1 (sensitivity, 76.6%; specificity, 72.5%; area under the receiver operating characteristic curve [AUC], 0.78; 95% CI, 0.75-0.81) at a cutoff of 0.18, and accuracy was 81.1% for model 2 (sensitivity, 78.0%; specificity, 81.5%; AUC, 0.86; 95% CI, 0.83-0.88) at a cutoff of 0.10. Both models demonstrated high AUCs on external (model 1: 0.75; 95% CI, 0.74-0.76) or internal (model 2: 0.82; 95% CI, 0.79-0.85) validation. CONCLUSIONS AND RELEVANCE: In this study, preoperative and postoperative prediction models for BCRL were highly accurate and clinically relevant tools comprised of accessible inputs and underscored the effects of racial differences on BCRL risk. The preoperative model identified high-risk patients who require close monitoring or preventative measures. The postoperative model can be used for screening of high-risk patients, thus decreasing the need for frequent clinic visits and arm volume measurements.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Rochlin DH, Barrio AV, McLaughlin S, et al. Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence. JAMA Surg. 2023. PMID: 37436762. doi:10.1001/jamasurg.2023.2414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。